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        Introduction 
  Differentiation of smooth muscle cells (SMCs) is a critical 
component of formation of the cardiovascular system. During 
the process of arteriogenesis, endothelial cell tubes become 
  invested with precursor cells, which subsequently differentiate 
into SMCs and form the medial layer of the blood vessels (for 
reviews see   Carmeliet, 2000  ;   Owens et al., 2004  ). Although 
the primary function of differentiated SMCs is contraction, 
SMCs during embryonic development also exhibit high rates 
of cell proliferation, migration, and production of extracellular 
matrix proteins that are required for vessel morphogenesis. 
SMC differentiation is characterized by coordinate induction 
of expression of a unique repertoire of SMC differentiation 
markers, including SM    -actin,  SM22   , SM-myosin heavy chain, 
and h1-calponin. However, the molecular mechanisms control-
ling SMC differentiation during early stages of arteriogenesis 
are poorly understood. 
  Expression of SMC differentiation markers has been shown 
to be controlled by a combinatorial interaction of multiple tran-
scription factors and cofactors (for review see  Owens et al., 2004 ). 
The promoter-enhancer regions of many SMC differentiation 
marker genes contain multiple CArG [CC(AT-rich)  6 GG]  ele-
ments, and the transbinding factor serum response factor 
(SRF) and its coactivator myocardin play a key role in the 
regulation of these genes. Indeed, results of previous studies 
from our laboratory and others showed that   myocardin   was 
exclusively expressed in SMCs and cardiomyocytes and that it 
markedly induced the transcription of multiple CArG-containing 
SMC differentiation marker genes in the presence of SRF, 
whereas suppression of myocardin by either dominant-negative 
constructs or siRNA was associated with marked decreases in 
transcription of these genes in cultured aortic SMCs (  Wang 
et al., 2001  ;   Chen et al., 2002  ;   Du et al., 2003  ;   Yoshida et al., 
2003  ). In addition, we showed that myocardin served as a point 
of convergence in mediating effects of environmental cues on 
expression of SMC differentiation marker genes, in that angio-
tensin II and platelet-derived growth factor BB regulated ex-
pression of CArG-containing SMC differentiation marker genes 
via changes in   myocardin   expression in cultured aortic SMCs 
(  Yoshida et al., 2004a, 2007  ;   Liu et al., 2005  ). However, myo-
cardin does not appear to be required for the initial induction of 
SMC lineage because recent studies revealed that   myocardin -
null embryonic stem (ES) cells were able to differentiate into 
SMCs in the context of chimeric knockout mice, which were 
generated by injection of   myocardin  -null ES cells into the wild-
type blastocysts in vivo (  Pipes et al., 2005  ). Moreover, results of 
in situ hybridization assays showed that   myocardin   expression 
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of major signifi  cance that   >  80% of A404 cells showed induc-
tion of SM     -actin upon treatment with a single reagent, RA, 
indicating that A404 is a clonal cell line poised for induction of 
SMC lineage. In addition, RA-induced differentiation of A404 
cells into SMCs was accompanied by increases in histone acety-
lation levels and SRF binding within the CArG-containing pro-
moter regions of SMC differentiation marker genes (  Manabe 
and Owens, 2001  ). Collectively, these results suggest that the 
A404 SMC differentiation system is a valuable model for study-
ing early stages of induction of SMC lineage from multipoten-
tial stem cells. 
  In the present studies, we performed a subtractive hybrid-
ization screen between undifferentiated and differentiated A404 
cells to identify factors critical for the initial induction of SMC 
differentiation. We discovered Pitx2 as a homeodomain transcrip-
tion factor that was rapidly induced during the differentiation of 
SMCs, as compared with the delayed induction of Prx1. We show 
that Pitx2 induces expression of multiple SMC differentiation 
marker genes by binding to specifi  c cis-regulatory elements, by 
interacting with SRF, and by increasing histone acetylation lev-
els within the promoter regions of SMC differentiation marker 
genes. Moreover, we show that knockout of the   Pitx2   gene  in 
mouse embryos virtually abolishes the induction of SMC dif-
ferentiation markers in early stages of SMC differentiation, thus 
providing the fi  rst evidence implicating a homeodomain protein 
in regulation of SMC development in vivo. 
  Results 
    Pitx2   expression was induced in 
multiple inducible culture models of 
SMC differentiation 
  To identify factors that play a key role in the initial induction 
of SMC differentiation, a subtractive hybridization screen was 
performed between undifferentiated A404 cells and differenti-
ated A404 cells that were treated with RA for 48 h. 44 genes 
were found to be induced in differentiated A404 cells as com-
pared with undifferentiated A404 cells (Table S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200711145/DC1). 
was quite low or undetectable in early developmental stages of 
vascular SMCs (  Wang et al., 2001  ;   Du et al., 2003  ). As such, al-
though the preceding results provide compelling evidence that 
the CArG  –  SRF  –  myocardin complex plays a key role in the con-
trol of SMC differentiation marker gene expression in differen-
tiated SMCs, the initial induction of SMC differentiation may 
not be dependent on myocardin and may be regulated through 
alternative molecular mechanisms. 
  Results of our previous studies have shown that Prx1 (also 
called as   Prrx1   and MHox), a homeodomain protein, plays 
a key role in basal and angiotensin II  –  induced expression of 
SMC differentiation marker genes in adult differentiated SMCs 
in vitro (  Hautmann et al., 1997  ;   Yoshida et al., 2004a  ). Treat-
ment with angiotensin II in fully differentiated cultured SMCs 
increased expression of   Prx1   as well as   SM    -actin .  In  addition, 
siRNA-induced suppression of   Prx1   decreased basal and angio-
tensin II  –  induced expression of   SM    -actin   in  differentiated 
SMCs. Moreover, recombinant Prx1 protein enhanced the bind-
ing of SRF to CArG elements within the   SM    -actin   promoter, 
although studies failed to detect the stable interaction between 
SRF and Prx1. These studies suggest that Prx1 is important 
in mediating angiotensin II  –  induced SMC hypertrophy in dif-
ferentiated SMCs. However, there is no evidence showing that 
Prx1 plays a role in regulating SMC differentiation marker 
genes during SMC development or in SMC hypertrophy in vivo. 
Indeed,   Bergwerff et al. [2000]   found no evidence of defective 
SMC differentiation within developing embryos in   Prx1 ,   Prx2 , 
or   Prx1/Prx2   knockout mice. At present, there is no direct evi-
dence that homeodomain proteins regulate SMC differentiation 
in vivo. 
  We previously developed an in vitro inducible SMC 
differentiation lineage system derived from clonal lines of mul-
tipotential P19 embryonal carcinoma cells harboring an   SM 
   -actin   promoter-enhancer – driven  puromycin-resistant  gene 
(  Manabe and Owens, 2001  ). One of these clonal lines, desig-
nated   “  A404,  ”   lacked expression of any known SMC differenti-
ation marker gene under basal conditions but showed induction 
of all known SMC differentiation marker genes in response to 
treatment with all transretinoic acid (RA) and puromycin. It is 
  Figure 1.         Pitx2   is induced during SMC dif-
ferentiation.   (A  –  C) A404 cells were induced 
to differentiate into SMCs by treatment with 
1   μ  g/ml RA, followed by 0.5-  μ  g/ml puromycin 
treatment. Expression of   Pitx2   (A),   SM     -actin   
(B), and   Prx1   (C) was determined by real-time 
RT-PCR from day (D) 0 to day 7. (D) Expression 
of   Pitx2   isoforms was determined by semiquan-
titative RT-PCR in undifferentiated A404 cells 
and RA-treated A404 cells for 48 h. PCR pro-
ducts are 424 bp for   Pitx2a  , 297 bp for   Pitx2b  , 
234 bp for   Pitx2c  , and 230 bp for   GAPDH  . 
(E and F) ES cells were induced to differentiate 
into SMCs in an embryoid body system, and 
expression of   Pitx2   (E) and   SM     -actin   (F) was 
determined by real-time RT-PCR at days 7, 15, 
and 28. Values represent the mean   ±   SEM of 
three independent experiments.     463 PITX2 INDUCES SMC DIFFERENTIATION   •   Shang et al.
  Pitx2 was required for the induction 
of SMC differentiation marker genes 
in multiple inducible culture models 
of SMC differentiation 
  To determine the role of Pitx2 in SMC differentiation, effects 
of overexpression of Pitx2 on SMC differentiation marker 
genes were examined. Expression plasmids for Pitx2 isoforms 
were cotransfected with the   SM    -actin   promoter-reporter 
construct into undifferentiated (non-RA treated) A404 cells. 
Results showed that each Pitx2 isoform increased transcriptional 
activity of the   SM    -actin   gene in a similar manner (  Fig. 2 A  ). 
The induction of   SM    -actin   transcription by Pitx2 was also 
seen in 10T1/2 cells, although it was modest in NIH/3T3 cells 
(unpublished data). To determine if Pitx2 induces expression 
of endogenous SMC differentiation marker genes, an adeno-
virus expressing Flag-tagged Pitx2a was constructed. Adeno-
virus-mediated overexpression of Pitx2 dramatically induced 
expression of multiple SMC differentiation marker genes in-
cluding   SM    -actin ,   SM22     ,  and   h1-calponin   in  A404  cells, 
although a subset of SMC differentiation marker genes, including 
  aortic carboxypeptidase-like protein  ( ACLP ) and  smoothelin-B , 
were not induced (  Fig. 2 B  ). Adenovirus-mediated overexpres-
sion of Pitx2 also increased cellular growth (Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200711145/DC1). 
Among these, Pitx2 was selected for further studies, because it 
is expressed in vascular SMCs during embryonic development 
(  Kitamura et al., 1999  ;   Hjalt et al., 2000  ) and it is a transcription 
factor implicated in the development of multiple organs such as 
the pituitary gland, the eyes, and the heart (  Gage et al., 1999  ; 
  Kitamura et al., 1999  ;   Lin et al., 1999  ;   Lu et al., 1999a  ). As an 
initial test of the potential importance of Pitx2 for SMC dif-
ferentiation, we examined its expression in multiple inducible 
culture systems of SMC differentiation. Expression of   Pitx2  
was rapidly induced by 5.5-fold, 48 h after RA treatment in 
A404 cells (  Fig. 1 A  ). The increase in   Pitx2   expression pre-
ceded the induction of   SM    -actin   and   Prx1   (  Fig. 1, B and C  ), 
and all   Pitx2   isoforms were induced (  Fig. 1 D  ). Expression of 
  Pitx2   was also examined in an ES cell  –  derived embryoid body 
model of SMC differentiation, which showed induction of SMC 
lineage in response to treatment with RA and dibutyryl cAMP 
(  Drab et al., 1997  ;   Sinha et al., 2004  ). Importantly, ES cell  – 
derived SMCs exhibited spontaneous contraction in the context 
of embryoid bodies, indicating that all regulatory pathways 
essential for formation of contractile SMCs are present within 
in this system. Expression of   Pitx2   was induced by sevenfold 
during the formation of embryoid bodies (  Fig. 1, E and F  ). 
These results show that   Pitx2   is induced in multiple in vitro SMC 
differentiation models. 
  Figure 2.       Pitx2 induces expression of SMC 
differentiation marker genes.   (A) Luciferase as-
says were performed in undifferentiated A404 
cells cotransfected with expression plasmids 
for Pitx2 isoforms and the   SM     -actin   promoter-
enhancer-luciferase construct. RLA, relative 
luciferase activity. (B) Undifferentiated A404 
cells were infected with adenovirus expressing 
Pitx2a or empty adenovirus, and expression of 
SMC differentiation marker genes was deter-
mined by real-time RT-PCR. (C) Efﬁ  ciency and 
speciﬁ   city of   Pitx2   siRNA were examined in 
COS cells cotransfected with Flag-Pitx2a ex-
pression plasmid and   Pitx2   siRNA expression 
plasmid or control plasmids. pMighty-Empty 
contained no target sequence and pMighty-
    Scr targeted scrambled sequence. (D) A404 
cells were induced to differentiate into SMCs 
by RA treatment for 1 d (early) or by RA treat-
ment for 3 d followed by puromycin selection 
for 2 d (late). Cells were transfected with the 
  SM     -actin   promoter-enhancer-luciferase con-
struct and a siRNA expression plasmid for 
  Pitx2   (pMighty-    Pitx2),   Prx1   (pMighty-    Prx1), 
or pMighty-    Scr. Luciferase assays were per-
formed. (E and F) A404 cells were induced 
to differentiate into SMCs by RA treatment 
and were transfected with siRNA duplexes for 
  Pitx2   or   EGFP  . Expression of SMC differenti-
ation marker genes was determined by real-
time RT-PCR (E) or Western blotting (F). Values 
represent the mean   ±   SEM of three indepen-
dent experiments.     JCB • VOLUME 181 • NUMBER 3 • 2008  464
As shown in   Fig. 2 D  , siRNA-induced suppression of   Pitx2  
reduced the transcriptional activity of the   SM    -actin   gene 
by 70% in early time points of SMC differentiation in RA-
treated A404 cells. In contrast, siRNA-induced suppression 
of   Prx1   did not decrease the   SM    -actin   activity under these 
conditions. However, the reduction in the transcriptional ac-
tivity of the   SM    -actin   gene by the   Pitx2   siRNA was blunted 
at later time points of SMC differentiation in differentiated 
A404 cells treated with RA and puromycin, whereas   Prx1  
siRNA reduced the activity more effectively at the same later 
time points. Transfection of   Pitx2   siRNA duplexes into A404 
cells revealed that RA-mediated induction of SMC differ-
entiation marker genes, including   SM    -actin ,   SM22     ,  and 
  h1-calponin   but not   ACLP   and   smoothelin-B  , was attenuated 
by 40  –  60% (  Fig. 2, E and F  ). These results suggest that Pitx2 
and Prx1 play complementary roles in control of SMC dif-
ferentiation marker gene expression but at different stages of 
SMC differentiation. 
Although increased growth is usually associated with reduced 
expression of SMC differentiation markers in fully differenti-
ated SMCs (for review see   Owens et al., 2004  ), it is possible 
that enhanced growth and subsequent changes in cell density 
and cell  –  cell interactions may contribute to Pitx2-induced dif-
ferentiation. However, the fact that Pitx2 selectively induced a 
subset of SMC differentiation marker genes suggests that this 
is not the case. 
  Effects of siRNA-induced knockdown of   Pitx2   on SMC 
differentiation marker genes were examined in differentiated 
A404 cells. The   Pitx2   siRNA expression plasmid, which tar-
gets a sequence that is common for all three   Pitx2   isoforms, 
was generated in a customized pMighty system that expresses 
siRNA under a mouse H1 promoter (  Yoshida et al., 2003  ). 
Cotransfection of   Pitx2   siRNA expression plasmid (pMighty-
    Pitx2) and Pitx2a expression plasmid revealed that   Pitx2  
siRNA effi  ciently and selectively suppressed expression of 
Pitx2 but not expression of a nontargeted protein, SRF (  Fig. 2 C  ). 
  Figure 3.       Induction of SMC differentiation marker genes is attenuated in embryoid bodies derived from   Pitx2   homozygous knockout ES cells.   (A) Geno-
typing of   Pitx2   knockout ES cells. (B)   Pitx2   knockout ES cells were stained with Oct4, Sox2, and SSEA-1. (C  –  E) Five independent   Pitx2   homozygous knockout 
ES cells, two   Pitx2   heterozygous knockout ES cells, and wild-type ES cells were induced to differentiate into SMCs in context of embryoid bodies, and ex-
pression of   SM     -actin  ,   SM22      , and   ACLP   was determined by real-time RT-PCR (C) and ﬂ  ow cytometry (D and E). Representative data from ﬂ  ow cytometry 
is shown in D. WT, wild-type; Het, heterozygous; KO, knockout. Values represent the mean   ±   SEM from three independent experiments.     465 PITX2 INDUCES SMC DIFFERENTIATION   •   Shang et al.
induced activation of the    125/+23-bp   SM    -actin   promoter-
luciferase construct was only 2.1-fold, suggesting that the 
sequence from     155 to     125 bp contains cis-regulatory ele-
ments important for Pitx2-induced activity. We previously 
identifi  ed an ATTA element within the   SM    -actin   promoter 
at     145 bp as a Prx1 binding site (  Hautmann et al., 1997  ). 
We noticed that this element was highly homologous to the Pitx2 
consensus DNA binding element 5   -TAATC(C/T)-3    in the 
reverse orientation and therefore tested the effect of mutation 
of this element on the Pitx2 response. Results showed that mu-
tation of the TAATCT element within the   SM    -actin   promoter-
luciferase construct reduced the responsiveness to Pitx2 as 
compared with the wild-type counterpart (  Fig. 4 B  ). A consen-
sus TAATCC element is also located at     1071 bp within the 
mouse   SM22       gene. Mutagenesis experiments revealed that 
this element was important for Pitx2-induced activation of the 
  SM22       gene (  Fig. 4 C  ). 
  To determine if Pitx2 binds to the TAATCT element within 
the   SM    -actin   promoter, electrophoresis mobility shift assays 
(EMSA) were performed using the double-stranded oligonucleo-
tide corresponding to the    156  to     131 bp of the   SM    -actin  
promoter and nuclear extracts from A404 cells. The oligonucleo-
tide containing the TAATCT element formed a slowly migrating 
complex with nuclear extracts from differentiated A404 cells but 
not those from undifferentiated A404 cells (  Fig. 4 D  ). This com-
plex was eliminated by cold-competitor oligonucleotide or by 
addition of an anti-Pitx2 antibody, demonstrating the specifi  c 
Pitx2 binding to the TAATCT element. Binding of Pitx2 to the 
TAATC(C/T) element-containing regions of SMC differentiation 
marker genes was also examined by chromatin immunoprecipita-
tion (ChIP) assays. Results showed that RA treatment induced 
the association of Pitx2 with the TAATC(C/T)-containing regions 
within the   SM    -actin   and   SM22       genes but not with the fi  rst 
  intron region of the   SM22       gene, which lacks the TAATC(C/T) 
element, in A404 cells (  Fig. 4 E  ). Pitx2 binding to these regions 
was decreased in later stages of differentiated A404 cells when 
expression of SMC differentiation marker genes was not dependent 
on Pitx2. Collectively, results provide evidence that binding of 
Pitx2 to the TAATC(C/T) element within the promoter-enhancer 
regions of SMC differentiation marker genes is required for in-
duction of these genes during SMC differentiation. 
  Pitx2 and SRF synergistically enhanced 
the transcriptional activity of SMC 
differentiation marker genes 
  Results thus far have shown that Pitx2 induces a subset of SMC 
differentiation marker genes that contain CArG elements within 
their promoter-enhancers. Thus, we tested the hypothesis that 
Pitx2 regulates SMC differentiation marker genes by inter-
acting with the CArG  –  SRF complex. First, cotransfection experi-
ments were performed using expression plasmids for Pitx2a and 
SRF as well as the   SM    -actin   promoter-luciferase construct. 
Results showed that Pitx2 and SRF synergistically induced the 
  SM    -actin   transcriptional activity in A404 cells (  Fig. 5 A  ). 
Second, effects of mutation of the CArG elements on Pitx2-
induced activation of the   SM    -actin   gene were tested in A404 
cells. Mutation of CArG B, CArG A, or double mutation of 
  Expression levels of   myocardin   and its related factors, 
  MKL1   and   MKL2  , were not altered in RA-treated A404 cells 
in the presence or absence of   Pitx2   siRNA (Fig. S2 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200711145/DC1). 
Pitx2-induced activation of the   SM    -actin   gene in A404 cells 
was not attenuated by siRNA-induced suppression of   myocardin . 
However, it was partially reduced by siRNAs for   MKL1   or   2   alone 
or in combination (Fig. S2 B). These results provide evidence 
that Pitx2-induced activation of SMC differentiation marker 
genes is not dependent on myocardin but is at least partially 
dependent on MKL1 and 2. 
  Loss-of-function experiments were also performed in the 
ES cell  –  derived embryoid body SMC differentiation system. 
As shown in   Fig. 3 A  , multiple independent clones of homozygous 
  Pitx2   knockout ES cells were isolated from heterozygous   Pitx2  
knockout ES cells using high G418 selection (  Mortensen et al., 
1992  ). Retention of pluripotency of each homozygous   Pitx2  
knockout ES cell line was validated based on positive immuno-
staining with ES cell markers, Oct4, Sox2, and stage-specifi  c 
embryonic antigen  –  1 (SSEA-1;   Fig. 3 B  ). Each homozygous 
  Pitx2   knockout cell line was then tested for its ability to dif-
ferentiate into SMCs in the context of embryoid bodies (  Sinha 
et al., 2004  ). In wild-type ES cell  –  derived embryoid bodies, 
expression of SMC differentiation marker genes, including   SM 
   -actin   and   SM22      , was induced by 109-fold and 18-fold, 
respectively (  Fig. 3 C  ). However, induction of these SMC differ-
entiation marker genes was dramatically attenuated in   Pitx2 -null 
embryoid bodies derived from all fi  ve independent lines of homo-
zygous   Pitx2   knockout ES cells, whereas induction of   ACLP  
expression was not affected. Expression of other lineage markers, 
including   PECAM ,   cardiac    -actin  , and   NeuroD  , was unaffected 
by deletion of the   Pitx2   gene (Fig. S3, available at http://www
.jcb.org/cgi/content/full/jcb.200711145/DC1). Induction of   SM 
   -actin   and   SM22       expression in heterozygous   Pitx2   knockout 
ES cells was also partially impaired, which is consistent with 
the fact that Axenfeld-Rieger syndrome, a disease caused by 
the mutation of the   Pitx2   gene, is a haploinsuffi  ciency disorder 
(  Semina et al., 1996  ). Furthermore, induction of SM    -actin  pro-
tein expression was attenuated in   Pitx2  -null embryoid bodies as 
determined by fl  ow cytometry (  Fig. 3, D and E  ). Collectively, 
results from a combination of gain- and loss-of-function ex-
periments provide compelling evidence that Pitx2 is critical for 
initial induction of SMC differentiation marker genes in multi-
potential stem cells. 
  Pitx2-induced expression of SMC 
differentiation marker genes via binding to 
a TAATC(C/T) element 
  To determine the molecular mechanisms whereby Pitx2 in-
duces expression of SMC differentiation marker genes, various 
mutation constructs of the   SM    -actin   promoter-enhancer-
luciferase plasmid (  Fig. 4 A  ) were cotransfected with Pitx2a 
expression plasmid into A404 cells. As shown in   Fig. 4 B  , Pitx2 
induced the transcriptional activity of the full-length    2.6/+2.8-kb 
  SM    -actin   promoter-enhancer-luciferase construct by 5.4-fold 
and the activity of the deletion construct, the    155/+21-bp 
  SM    -actin   promoter-luciferase, by 4.5-fold. However, Pitx2-JCB • VOLUME 181 • NUMBER 3 • 2008  466
hibit SRF interaction. Moreover, a deletion mutant, Pitx2a (aa 
39  –  100), which only contained the homeodomain, interacted 
with SRF, indicating that the homeodomain of Pitx2, which is 
common for all three Pitx2 isoforms, is suffi  cient for the physi-
cal interaction with SRF. 
  The domain of SRF required for Pitx2 interaction was 
determined by GST pulldown assays and mammalian two-
hybrid assays. Although the full-length SRF bound to Pitx2, 
neither SRF (aa 1  –  222) nor SRF (aa 1  –  132) truncation mutants 
bound to Pitx2 as determined by GST pulldown assays (  Fig. 5 D  ). 
In support of this, results of mammalian two-hybrid assays 
showed that the domain of SRF from aa 266 to 414 was re-
quired for Pitx2 interaction (  Fig. 5 E  ). Higher basal activities 
observed in GAL4-SRF (aa 168  –  508), GAL4-SRF (aa 266  –
  508), and GAL4-SRF (aa 414  –  508) constructs may be caused 
by the lack of amino-terminal domain, which inhibits the acti-
vation domain of SRF (  Johansen and Prywes, 1993  ). Collec-
tively, these results suggest that the homeodomain of Pitx2 
(aa 39  –  100) directly binds to the carboxy-terminal domain 
(aa 266 – 414)  of  SRF. 
CArGs B and A each decreased the response to Pitx2 (  Fig. 5 B  ). 
These results suggest that Pitx2-induced   SM    -actin   transcrip-
tion is mediated in part through the CArG  –  SRF complex. How-
ever, the TAATCT element was not required for SRF-induction 
of the   SM    -actin   gene (Fig. S4, available at http://www.jcb
.org/cgi/content/full/jcb.200711145/DC1). 
  To determine if the synergistic effect of Pitx2 and SRF 
was caused by the direct interaction of these two proteins, co-
immunoprecipitation assays were performed using expression 
plasmids for Flag-tagged Pitx2a and SRF. Interaction was read-
ily detectable between Pitx2a and SRF (  Fig. 5 C  ). The domain 
of Pitx2a required for SRF interaction was then determined by 
using Pitx2a deletion mutants. Although deletions from aa 101 
to the carboxy terminus (Pitx2a [aa 1  –  208], Pitx2a [aa 1  –  189], 
and Pitx2a [aa 1  –  101]) did not affect SRF interaction, Pitx2a 
(aa 1  –  49), which lacked the homeodomain and the carboxy-
terminal domain, failed to interact with SRF. In addition, although 
a deletion of the amino terminus to aa 38 (Pitx2a [aa 39  –  271]) 
did not affect SRF interaction, Pitx2a (aa 98 – 271), which lacked 
the homeodomain and the amino-terminal domain, did not ex-
  Figure 4.       Pitx2 induces SMC differentiation 
marker genes by binding to the TAATC(C/T) 
element.   (A) Schematic structure of the   SM 
    -actin   promoter. CArG B, CArG A, and a 
TAATCC element are shown. (B and C) Luciferase 
assays were performed in A404 cells cotrans-
fected with Pitx2a expression plasmid and the 
promoter-enhancer-luciferase construct of the 
  SM     -actin   (B) and   SM22       (C) genes. Sche-
matic representation of mutation constructs is 
shown on the left. Values represent the mean   ±   
SEM from three independent experiments. 
(D) EMSA was performed using the  
32  P-labeled 
double-stranded oligonucleotide containing 
the TAATCT element of the   SM     -actin   gene 
and nuclear extracts from undifferentiated and 
differentiated A404 cells. Antibodies for Pitx2 
(P) or SRF (S) were used to test interference. 
Arrowhead indicates a labeled oligonucleotide  –
  Pitx2 protein complex. (E) Association of Pitx2 
with the TAATC(C/T) region of the   SM     -actin   
and   SM22       genes or the ﬁ  rst intron region of 
the   SM22       gene was determined by ChIP as-
says in undifferentiated A404 cells, differenti-
ated A404 cells treated with RA for 2 d (early), 
and differentiated A404 cells treated with RA 
for 3 d followed by puromycin selection for 2 d 
(late). Values represent the mean   ±   SEM from 
three independent experiments.     467 PITX2 INDUCES SMC DIFFERENTIATION   •   Shang et al.
  Pitx2 induced acetylation of histone 
H4 at the promoter regions of SMC 
differentiation marker genes through the 
exchange of histone deacetylase (HDAC) 2 
and HDAC5 with p300 
  Previous studies from our laboratory showed that RA-induced 
SMC differentiation in A404 cells was accompanied by the 
  increase in the acetylation levels of histone H4 at the promoter 
regions of SMC differentiation marker genes (  Manabe and Owens, 
2001  ). The acetylation status of histones at the promoter re-
gions of SMC differentiation marker genes has been shown to 
be regulated by the histone acetyltransferase p300 and multiple 
HDACs (  Qiu and Li, 2002  ;   Yoshida et al., 2007  ). We thus tested 
  Because results of our previous studies showed that SRF 
was associated with CArG elements of SMC differentiation 
marker genes in differentiated, but not in undifferentiated A404 
cells (  Manabe and Owens, 2001  ), we tested if Pitx2 alters the 
binding affi  nity of SRF with CArG elements of SMC differentia-
tion marker genes. Adenovirus-mediated overexpression of Pitx2 
did not change SRF expression levels, but it greatly enhanced the 
association of SRF with the CArG-containing region of the   SM 
   -actin   promoter in A404 cells, as determined by ChIP assays 
(  Fig. 5 F  ). Results suggest that Pitx2 induces expression of SMC 
differentiation marker genes, in part by interacting with SRF and 
increasing the association of SRF with the CArG elements within 
the promoter regions of SMC differentiation marker genes. 
  Figure 5.       Pitx2 and SRF synergistically induce SMC differentiation marker genes.   (A) Luciferase assays were performed in A404 cells cotransfected with 
expression plasmids for Pitx2a and SRF and the   SM     -actin   promoter-enhancer-luciferase construct. (B) Luciferase assays were performed in A404 cells 
cotransfected with Pitx2a expression plasmid and mutation constructs of the   SM     -actin   gene. (C) Coimmunoprecipitation assays were performed in COS 
cells cotransfected with SRF expression plasmid and wild-type Pitx2a expression plasmid or deletion mutants. Schematic representation of Pitx2a dele-
tion constructs is shown (top). Numbers indicate the position of amino acids. (D) GST pulldown assays were performed using Myc-tagged Pitx2a protein 
and GST-SRF fusion protein or its deletion mutants. Asterisks indicate GST-SRF protein and its deletion mutants. (E) Mammalian two-hybrid assays were 
performed in Balb/c 3T3 cells. (F) A404 cells were infected with adenovirus expressing Pitx2a or empty adenovirus, and the association of SRF with the 
CArG-containing region of the   SM     -actin   gene was determined by ChIP assays. Values represent the mean   ±   SEM of three independent experiments. 
Expression of SRF and GAPDH protein in A404 cells infected with adenovirus expressing Pitx2a or empty adenovirus are also shown.     JCB • VOLUME 181 • NUMBER 3 • 2008  468
multiple abnormalities, including the failure of ventral body 
wall closure, right pulmonary isomerism, altered cardiac posi-
tioning with valvular and atrial septation defects, and abnormal 
morphogenesis of the eyes, teeth, and pituitary gland (  Gage 
et al., 1999  ;   Kitamura et al., 1999  ;   Lin et al., 1999  ;   Lu et al., 
1999a  ). To extend our preceding results from cultured cells to 
the in vivo circumstances, the role of Pitx2 in SMC differentia-
tion was examined in   Pitx2   knockout mouse embryos. Hetero-
zygous   Pitx2   mice were intercrossed, and expression of SMC 
differentiation markers, including SM     -actin and SM22   , 
was examined in   Pitx2   knockout mouse embryos by immuno-
histochemistry (  Figs. 7 and 8  ). Expression of both SM    -actin 
(  Fig. 7 C and Fig. 8 C  ) and SM22     (  Fig. 7 F  ) was virtually 
abolished in both the left and right sides of the third, fourth, 
and sixth branchial arch arteries and the dorsal aorta of homo-
zygous   Pitx2   knockout embryos at E11.5, as well as at E10.5 
and 12.5 (not depicted). Expression of these SMC differentia-
tion markers was also decreased in vessels of heterozygous 
  Pitx2   knockout mouse embryos (  Fig. 7, B and E; and Fig. 8 B  ), 
as compared with the wild-type embryos (  Fig. 7, A and D; and 
Fig. 8 A  ). In contrast, expression of ACLP was not decreased in 
  Pitx2   knockout mouse embryos (  Fig. 7, G, I, and K; and Fig. 8, 
D  –  F  ). Pitx2 expression was seen in SMCs of wild-type mouse 
embryos, whereas it was abolished in   Pitx2   knockout mouse 
embryos ( Fig. 7, M – O; and Fig. 8, J – L ). Expression of PECAM, 
an endothelial marker, was not altered in   Pitx2   knockout em-
bryos (  Fig. 7, H, J, and L; and Fig. 8, G  –  I  ), suggesting that the 
formation of the endothelial tube is not impaired and that dele-
tion of the   Pitx2   gene exhibits a selective effect on SMC differ-
entiation rather than the general effects on vessel formation. 
At E13.5, expression of SMC differentiation markers, including 
the hypothesis that changes in the histone acetylation status, 
through control of the balance between p300 and HDACs at the 
promoter regions of SMC differentiation marker genes, contrib-
ute to Pitx2-induced activation of SMC differentiation marker 
genes in A404 cells. This hypothesis was supported by the 
following experiments. First, results of ChIP assays showed 
that adenovirus-mediated overexpression of Pitx2 increased the 
acetylation levels of histone H4 within the promoter region of 
the   SM    -actin   gene in A404 cells (  Fig. 6 A  ). Second, cotrans-
fection experiments revealed that p300 enhanced Pitx2-induced 
activation of the   SM    -actin   gene, whereas HDAC2 and 5 mark-
edly repressed it in A404 cells (  Fig. 6, B and C  ). Third, siRNA 
experiments showed that knockdown of   p300   decreased Pitx2-
induced activation of the   SM    -actin   gene (  Fig. 6 C  ). Finally, 
results of ChIP assays showed that adenovirus-mediated over-
expression of Pitx2 increased the association of p300 with the 
promoter region of the   SM    -actin   gene, whereas it decreased the 
association of HDAC2 and 5 in A404 cells (  Fig. 6 D  ). Collectively, 
these results suggest that Pitx2-induced activation of SMC dif-
ferentiation marker genes is mediated, at least in part, through 
the exchange of HDAC2 and 5 with p300 at the promoter regions 
of SMC differentiation marker genes, which in turn results in 
increased acetylation levels of histone H4 and enhanced tran-
scription of SMC differentiation marker genes. 
  Knockout of the   Pitx2   gene in mice 
abolished expression of SMC 
differentiation markers in vessels during 
the early embryogenesis 
  Knockout of the   Pitx2   gene in mice has been shown to result in 
embryonic lethality by embryonic day (E) 14.5 because of 
  Figure 6.       Pitx2 induces acetylation of histone H4 at the promoter regions of SMC differentiation marker genes.   (A) A404 cells were infected with adeno-
virus expressing Pitx2a or empty adenovirus, and acetylation levels of histone H4 at the promoter region of the   SM     -actin   gene were determined by ChIP 
assays. (B) Luciferase assays were performed in A404 cells cotransfected with HDAC expression plasmids, Pitx2a expression plasmid, and the   SM     -actin   
promoter-enhancer-luciferase construct. (C, left) Efﬁ  ciency of   p300   siRNA was tested by Western blotting. (C, right) Luciferase assays were performed in 
A404 cells cotransfected with Pitx2a expression plasmid, expression plasmid for p300 or   p300   siRNA, and the   SM     -actin   promoter-enhancer-luciferase 
construct. (D) A404 cells were infected with adenovirus expressing Pitx2a or empty adenovirus, and the association of p300, HDAC2, and HDAC5 with the 
CArG-containing region of the   SM     -actin   gene was determined by ChIP assays. Values represent the mean   ±   SEM of three independent experiments.     469 PITX2 INDUCES SMC DIFFERENTIATION   •   Shang et al.
factor for directing the left-right asymmetry (  Liu et al., 2001  ). 
Indeed, mutation of the   Pitx2   gene in human causes Axenfeld-
Rieger syndrome, an autosomal-dominant disorder character-
ized by ocular anterior chamber anomalies causing glaucoma, 
dental hypoplasia, craniofacial dysmorphism, umbilical stump 
abnormalities, and abnormal development of the heart and pitu-
itary gland (  Semina et al., 1996  ). As such, although it is clear 
that Pitx2 is required for proper embryonic development, the 
role and mechanisms by which Pitx2 infl  uences differentiation 
of the vascular system were unclear. In the present studies, we 
provide several lines of evidence indicating that Pitx2 plays a 
key role in the initial induction of SMC differentiation. First, 
overexpression of Pitx2 induced expression of multiple SMC 
differentiation marker genes, including   SM    -actin ,   SM22     , 
and   h1-calponin  , whereas knockout of the   Pitx2   gene attenu-
ated the induction of these SMC differentiation marker genes in 
SM     -actin and SM22    , was not decreased in any vessels in 
  Pitx2   knockout mouse embryos (unpublished data). Moreover, 
analysis of   Prx1   knockout mouse embryos revealed that SM 
    -actin expression was not decreased in any vessels at E11.5 
(  Fig. 7, P  –  R  ). These results suggest that Pitx2, but not Prx1, is 
required for the initial induction of SMC differentiation during 
early embryonic development but can be compensated by other 
factors at later developmental time points. 
  Discussion 
  Pitx2 is a   bicoid  -related homeodomain transcription factor that 
plays a key role in the development of multiple organs, includ-
ing the heart, lung, eyes, teeth, and pituitary gland (  Gage et al., 
1999  ;   Kitamura et al., 1999  ;   Lin et al., 1999  ;   Lu et al., 1999a  ). 
In addition, the Pitx2c isoform has been shown to be a critical 
  Figure 7.       Expression of SMC differentiation markers 
is nearly abolished in vessels of   Pitx2   knockout mouse 
embryos.   (A  –  O) Expression of SM     -actin (A  –  C), 
SM22     (D  –  F), ACLP (G, I, and K), PECAM (H, J, 
and L), and Pitx2 (M  –  O) was examined by immuno-
histochemistry in wild-type (A, D, G, H, and M), 
heterozygous   Pitx2   knockout (B, E, I, J, and N), and 
homozygous   Pitx2   knockout (C, F, K, L, and O) mouse 
embryos at E11.5. (P  –  R) Expression of SM     -actin was 
examined by immunohistochemistry in wild-type (P), 
heterozygous   Prx1   knockout (Q), and homozygous 
  Prx1   knockout (R) mouse embryos at E11.5. III, third 
branchial arch artery; IV, fourth branchial arch artery; 
VI, sixth branchial arch artery; DA, dorsal aorta. Orig-
inal magniﬁ  cation, 40  ×  . Bars, 100   μ  m.     JCB • VOLUME 181 • NUMBER 3 • 2008  470
markers at the same time point during embryogenesis. More-
over, no evidence of defective SMC differentiation was found 
in   Prx1 ,   Prx2 ,  or   Prx1/Prx2   knockout mice (  Bergwerff et al., 
2000  ). Collectively, our results provide evidence that Pitx2 and 
Prx1 may play complementary roles in modulating SMC differ-
entiation marker gene expression but operate at different devel-
opmental stages. 
  Results of the present studies showed that knockout of 
the   Pitx2   gene was associated with marked decreases in ex-
pression of SMC differentiation marker genes that contain 
multiple CArG elements in their promoter-enhancers, including 
  SM    -actin   and   SM22      . Although several previous studies, in-
cluding our own, have reported that the CArG  –  SRF  –  myocardin 
complex plays an important role in the regulation of CArG-
containing SMC differentiation marker genes in differentiated 
SMCs (  Chen et al., 2002  ;   Du et al., 2003  ;   Yoshida et al., 2003  ), 
our present results suggest a novel mechanism wherein the ini-
tial induction of CArG-containing SMC differentiation marker 
genes is dependent on a combination of Pitx2 and SRF rather 
than a combination of myocardin and SRF, based on the fol-
lowing observations. First, we showed that the induction of 
SMC differentiation marker genes was dramatically attenuated 
multiple in vitro SMC differentiation model systems. Second, 
Pitx2-induced activation of SMC differentiation marker genes was 
mediated by a combination of mechanisms, including the fol-
lowing: the binding of Pitx2 to TAATC(C/T) cis-elements within 
the promoter regions of SMC differentiation marker genes; the 
interaction between Pitx2 and SRF; and Pitx2-mediated ex-
change of HDACs with p300 to increase the histone H4 acetylation 
levels at the promoter regions of SMC differentiation marker 
genes. It is of note that the TAATC(C/T) cis-elements within the 
  SM    -actin   and the   SM22       promoters were shown to be func-
tional, and a similar TAATCA sequence was found at +336 bp 
within the fi  rst intron of the mouse   h1-calponin   gene.  Third, 
knockout of the   Pitx2   gene in mice virtually abolished the ini-
tial induction of SMC differentiation markers in branchial arch 
arteries and the dorsal aorta during embryogenesis. Indeed, our 
demonstration of impaired induction of SMC differentiation 
markers in   Pitx2   knockout mouse embryos provides the fi  rst 
evidence that a homeodomain protein regulates SMC differenti-
ation in vivo. Although we previously showed that Prx1 plays 
a key role in angiotensin II  –  induced hypertrophy in cultured 
SMCs (  Hautmann et al., 1997  ;   Yoshida et al., 2004a  ),   Prx1  
knockout had no effect on expression of SMC differentiation 
  Figure 8.       Expression of SMC differentiation markers 
is nearly abolished in vessels of   Pitx2   knockout mouse 
embryos.   Expression of SM     -actin (A  –  C), ACLP (D  –  F), 
PECAM (G  –  I), and Pitx2 (J  –  L) was examined in the dorsal 
aorta of wild-type (A, D, G, and J), heterozygous   Pitx2   
knockout (B, E, H, and K), and homozygous   Pitx2   knock-
out (C, F, I, and L) mouse embryos at E11.5. Original 
magniﬁ  cation, 400  ×  . Bars, 20   μ  m.     471 PITX2 INDUCES SMC DIFFERENTIATION   •   Shang et al.
branchial arch arteries, as well as in the mesoderm-derived 
SMCs present in the dorsal aorta. These fi  ndings are consistent 
with results of previous studies showing that Pitx2 functioned in 
tissues from multiple embryological origins (  Evans and Gage, 
2005  ;   Ai et al., 2006  ). For example, studies using the cardiac 
second lineage  –  specifi  c   Pitx2   knockout mice showed that dele-
tion of the   Pitx2   gene in the cardiac second lineage, which was 
derived from mesoderm, caused severe defects in alignment of 
the cardiac outfl  ow tract (  Ai et al., 2006  ). In contrast, studies 
using neural crest  –  specifi  c   Pitx2   knockout mice revealed that 
Pitx2 expression in neural crest was required for optic stalk and 
ocular anterior segment development (  Evans and Gage, 2005  ). 
As such, the function of Pitx2 is unlikely to be restricted to the 
single embryological origin. Further analyses of expression of 
SMC differentiation marker genes in conditional   Pitx2   knock-
out mice will be required to better clarify the cell type  –  specifi  c 
requirement of Pitx2 for SMC differentiation from different 
embryological origins. 
  Our results provide evidence that Pitx2-induced activation 
of SMC differentiation marker genes is mediated, at least in part, 
by promoting exchange of HDAC2 and 5 with p300 within the 
promoter regions of SMC differentiation marker genes, thereby 
increasing acetylation levels of histone H4 and chromatin re-
laxation. Consistent with this model, we previously showed that 
platelet-derived growth factor BB  –  induced suppression of SMC 
differentiation marker genes was caused, in part, by HDAC-
mediated hypoacetylation of histone H4 within these promoters 
in cultured SMCs (  Yoshida et al., 2007  ). Pitx2-induced hyper-
acetylation of histones has also been reported previously (  Kioussi 
et al., 2002  ). The studies showed that Pitx2 activated transcrip-
tion of the   cyclin D2   gene by increasing the acetylation levels 
of histone H4 at the gene promoter. They presented evidence 
that these changes were dependent on exchange of HDAC1 with 
p300, which was mediated through association of Pitx2 and 
Wnt-activated     -catenin within the   cyclin D2   promoter. In addi-
tion, the interaction between Pitx2 and p300 has been shown by 
coimmunoprecipitation assays (  Kioussi et al., 2002  ), although 
it is possible that other factors are required for this interaction. 
During the embryonic development, SMCs have been shown 
to exhibit a high rate of proliferation while at the same time 
activating expression of SMC differentiation marker genes. It is 
interesting to speculate that Pitx2 may play a key role in regu-
lating both of these processes by cooperating with distinct part-
ner proteins such as     -catenin and SRF, respectively. 
  In summary, results of the present studies provide novel 
evidence that Pitx2 plays a critical role in the induction of SMC 
differentiation during the early embryogenesis. Further studies 
are needed to determine whether Pitx2 contributes to the patho-
physiology of vascular diseases such as atherosclerosis, hyper-
tension, and restenosis, where SMC phenotypic switching plays 
a key role. 
  Materials and methods 
  Plasmid constructs and siRNA duplexes 
  Rat     2.6/+2.8-kb   SM     -actin   promoter-enhancer-luciferase,     155/+21-bp 
  SM     -actin   promoter-luciferase, and     125/+23-bp   SM     -actin   promoter-
luciferase constructs were described previously (  Yoshida et al., 2003, 2004a  ). 
during SMC differentiation in the context of embryoid bodies 
derived from   Pitx2   knockout ES cells, whereas our previous 
studies showed that homozygous knockout of the   myocardin  
gene exhibited little effect on SMC differentiation in the same 
embryoid body system (  Pipes et al., 2005  ). Second, although 
recent studies showed the transcriptional activity of the   myo-
cardin   gene during early embryonic development (  Long et al., 
2007 ),   myocardin   mRNA was not readily detectable in vessels, 
including the descending aorta, until E12.5, as determined by 
in situ hybridization assays (  Wang et al., 2001  ;   Du et al., 2003  ). 
Third, results of recent studies (  Pipes et al., 2005  ) showed that 
  myocardin  -null ES cells were able to differentiate into SMCs 
in the context of chimeric knockout mice that were generated 
by injection of   myocardin  -null ES cells into the wild-type blas-
tocysts. As such, these fi  ndings support the hypothesis that 
the initial induction of SMC differentiation is not dependent 
on myocardin but is regulated through alternative molecular 
mechanisms including Pitx2 and SRF. It is of interest that re-
sults of our recent studies showed that   SM    -actin   expression 
during early stages of embryonic development is dependent on 
two MCAT elements located at     184 and     320 bp within rat 
  SM    -actin   promoter (  Gan et al., 2007  ). Indeed, mutation of 
MCAT elements in transgenic mice harboring an   SM    -actin  
promoter-enhancer-LacZ construct revealed that MCAT ele-
ments are required for   SM    -actin   expression at E10.5 and 12.5 
but dispensable after E13.5 through adulthood. It is thus inter-
esting to postulate that MCAT elements and their binding fac-
tor RTEF-1 may cooperatively regulate   SM    -actin   expression 
with Pitx2. However, Pitx2 effects on the transcriptional activity 
of the   SM    -actin   gene were not affected by mutation of MCAT 
elements (unpublished data). Moreover, MCAT elements are 
not present in the promoter regions of other SMC differentia-
tion marker genes (  Yoshida, 2008  ). Collectively, our results 
suggest that Pitx2 and RTEF-1/MCAT elements may regulate 
early induction of SMC differentiation markers through in-
dependent mechanisms. 
  Results of recent studies have provided evidence for di-
versity in transcriptional control of SMC differentiation among 
cells derived from different embryological origins. For exam-
ple, knockout of the   MKL2   (also called   MRTF-B  ) gene in mice 
resulted in defective formation of neural crest  –  derived bran-
chial arch arteries and severe reduction in SM    -actin  expres-
sion selectively in these vessels (  Li et al., 2005  ;   Oh et al., 2005  ). 
These defects were rescued by neural crest  –  specifi  c restoration 
of MKL2/MRTF-B expression, suggesting that MKL2/MRTF-B 
plays a critical role in regulating differentiation of neural 
crest cells into SMCs. In addition, results of studies in chick 
embryos also showed the diversity in differentiation of SMCs 
among distinct embryological origins in that they showed dif-
ferences in morphology, growth, and responsiveness to trans-
forming growth factor      between local mesoderm-derived SMCs 
and neural crest  –  derived SMCs (  Topouzis and Majesky, 1996  ). 
However, our results suggest that Pitx2 is required for SMC 
differentiation in at least two distinct embryological sources 
of SMCs. Indeed, expression of SMC differentiation markers 
in   Pitx2   knockout mouse embryos was abolished in neural 
crest  –  derived SMCs located at the third, fourth, and sixth JCB • VOLUME 181 • NUMBER 3 • 2008  472
  EMSA and ChIP assays 
  EMSA was performed as described previously (  Yoshida et al., 2003  ) using 
a double-stranded oligonucleotide (5    -CACCCAGATTAGAGAGTTTTGTG-3    ) 
or a mutated oligonucleotide (5    -CACCCAGCAGTGAGAGTTTGTG-3    ). 
ChIP assays were performed as previously described (  Yoshida et al., 
2007  ). Antibodies used were the following: SRF, Pitx2, acetyl histone H4 
(Millipore), p300 (Santa Cruz Biotechnology, Inc.), HDAC2 (Invitrogen), 
and HDAC5 (Cell Signaling Technology). Real-time PCR was performed to 
amplify the promoter region of the   SM     -actin   gene (  Manabe and Owens, 
2001  ), the TAATCC-containing region of the   SM22       gene (5    -TGGGATTA-
AAGGCGTGTGCCCA-3     and 5    -ATCCACTACAGCCAGCCTGGCT-3    ), 
or the ﬁ  rst intron region of the   SM22       gene (5    -AAGAAGGTGAGGGGC-
TAAGTTC-3     and 5    -TATCCCAGGCTAGTCTGAAGGA-3    ). 
  GST pulldown assays and mammalian two-hybrid assays 
  Myc-tagged Pix2a protein was translated in TnT Quick coupled transcription/
translation system (Promega). GST-tagged SRF and its truncated mutants 
were induced in   Escherichia coli   by the addition of 0.5 mmol/  L   isopropyl-
1-thio-    -  D  -galactopyranoside for 1 h at 37  °  C. Lysates were prepared by 
sonicating bacterial pellets in PBS containing 10% glycerin. Cleared lysates 
were incubated with Glutathione Sepharose 4B beads (GE Healthcare) for 
1 h at 4  °  C and washed three times with cold PBS containing 10% glycerin. 
Beads  –  protein complex was incubated with Myc-tagged Pitx2a protein for 
2 h at 4  °  C and washed three times. Beads-bound proteins were eluted by 
boiling and analyzed by Western blotting with anti-Myc antibody (Santa 
Cruz Biotechnology, Inc.). Mammalian two-hybrid assays were performed 
as previously described (  Yoshida et al., 2004a  ). 
  Flow cytometry 
  Embryoid bodies were washed with PBS and incubated with 1 mg/ml col-
lagenase type IV and 0.125% trypsin for 20 min at 37  °  C. Cells were ﬁ  xed 
in 2% PFA, permeabilized by ice-cold methanol, and incubated with FITC-
conjugated SM     -actin antibody (Sigma-Aldrich) or FITC-conjugated IgG 
as a negative control. Cells were analyzed using a FACSCalibur dual-laser 
benchtop cytometer (BD Biosciences). 
  Immunohistochemistry in mouse embryos 
  Heterozygous   Pitx2   
+/      mice (  Lu et al., 1999a  ) were purchased from the 
Mutant Mouse Regional Resource Center.   Prx1   knockout mice were de-
scribed previously (  Lu et al., 1999b  ). Heterozygous knockout mice were 
intercrossed to generate homozygous knockout mouse embryos. Embryos 
were harvested, ﬁ  xed in 10% neutral buffered formalin, and embedded 
into parafﬁ  n. Yolk sacs were used for genotyping. The 5-  μ  m sections were 
deparafﬁ  nized, rehydrated, and stained with antibodies for SM     -actin, 
SM22    , Pitx2, ACLP (  Yoshida et al., 2004b  ), and PECAM (BD Biosci-
ences). Staining was visualized by DAB or the Vector Blue Alkaline Phos-
phatase Substrate kit (Vector Laboratories) and counterstained by nuclear 
FastRed, hematoxylin or methylgreen. Images were obtained using a 
microscope (Axioskop 2; Carl Zeiss, Inc.) and camera (SPOT; Diagnostic 
Instruments, Inc.). Animal protocols were approved by the University of 
Virginia Animal Care and Use Committee. E0.5 was deﬁ  ned as noon of 
the day a vaginal plug was detected after overnight mating. 
  Online supplemental material 
  Fig. S1 shows growth rates of A404 cells infected with adenovirus ex-
pressing Pitx2 or control adenovirus. Fig. S2 shows involvement of MKL1, 
MKL2, and myocardin in Pitx2-induced activation of SMC differentiation 
marker genes in A404 cells. Fig. S3 shows expression of   PECAM  ,   cardiac 
    -actin  , and   NeuroD   in embryoid bodies derived from   Pitx2   homozygous 
knockout ES cells,   Pitx2   heterozygous ES cells, and wild-type ES cells. 
Fig. S4 shows mutational effects of a TAATCT element on SRF-induced acti-
vation of the   SM     -actin   gene. Table S1 shows a list of genes preferentially 
expressed in RA-treated A404 cells as compared with undifferentiated 
A404 cells. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200711145/DC1. 
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Mutations (TAATCT element at     145 bp, AGATTA to AGCAGT; CArG B at 
    112 bp, CCCTATATGG to AACTATATAA; and CArG A at     62 bp, CCTT-
GTTTGG to AATTGTTTAA) were introduced into     155/+21-bp   SM     -actin   
promoter-luciferase construct as described previously (  Yoshida et al., 2004a  ). 
Mouse 1343-bp   SM22       promoter-luciferase construct was provided by L. Li 
(Wayne State University, Detroit, MI) and mutation (GGATTA to GGCCCA) 
was introduced at     1071 bp by site-directed mutagenesis (  Li et al., 1996  ). 
An expression plasmid for Flag-tagged Pitx2a was constructed by inserting 
  Pitx2a   cDNA into pCMV7.1 3  ×  FLAG vector (Sigma-Aldrich). Deletion con-
structs of Flag-tagged Pitx2a were made by PCR. Expression plasmids for 
Myc-tagged Pitx2a, Pitx2b, and Pitx2c isoforms and SRF were described 
previously (  Ganga et al., 2003  ;   Liu et al., 2005  ). A siRNA expression plas-
mid targeting all   Pitx2   isoforms was constructed by inserting speciﬁ  c 
oligonucleotide (AGAAACCGCTACCCAGACA) into pMighty-Empty (  Yoshida 
et al., 2003  ). siRNA expression plasmids for   Prx1  ,   myocardin  ,   MKL1  , and 
  MKL2   were described previously (  Yoshida et al., 2003, 2004a, 2007  ). 
siRNA duplexes targeting   Pitx2   and   EGFP   were purchased from MWG Bio-
tech. Expression plasmids for HDAC1  –  5 were provided by S.L. Schreiber 
(Harvard University, Cambridge, MA) and E. Seto (H. Lee Mofﬁ  tt Cancer 
Center and Research Institute, Tampa, FL). An expression plasmid for p300 
was purchased from Millipore. A siRNA expression construct for   p300  , 
pSUPER-    p300, was provided by D.K. Granner (Vanderbilt University, 
Nashville, TN). GST-tagged SRF expression plasmid and its deletion mutants 
were provided by B.P. Herring (Indiana University, Indianapolis, IN). 
Expression plasmids for GAL4-SRF and truncated mutants were provided 
by R. Prywes (Columbia University, New York, NY). Expression plasmid 
for VP16-Pitx2a fusion protein was constructed as previously described 
(  Yoshida et al., 2004a  ). 
  Cell culture, transient transfection, and adenovirus infection 
  A404 cells were cultured and induced to differentiate into SMCs as de-
scribed previously (  Manabe and Owens, 2001  ). 10T1/2 cells and NIH/3T3 
cells were cultured as described previously (  Yoshida et al., 2003  ). Transfec-
tion of DNA plasmids was performed by using FuGene6 (Roche). Replica-
tion-deﬁ  cient adenovirus expressing Flag-tagged Pitx2a was generated and 
puriﬁ   ed by ViraQuest Inc. Infection of adenovirus expressing Flag-Pitx2a 
or empty adenovirus was performed at 50 MOI as previously described 
(  Yoshida et al., 2003  ). 
  Generation of   Pitx2   homozygous knockout ES cells 
  To obtain   Pitx2   homozygous knockout ES cells,   Pitx2   heterozygous knockout 
ES cells (  Lu et al., 1999a  ) were cultured with 2 mg/ml G418 for 21 d 
(  Mortensen et al., 1992  ). After 21 d, 192 independent clones were picked 
up, and ﬁ  ve clones were found to be   Pitx2   homozygous knockout ES cells by 
PCR genotyping. Two   Pitx2   heterozygous knockout ES cell clones that sur-
vived the selection protocol were also used for control. Pluripotency of these 
ES cells was conﬁ  rmed by immunostaining of ES cell markers including Oct4, 
Sox2, and SSEA-1 (Millipore). Procedures for differentiation of ES cells into 
SMCs in the context of embryoid bodies were described previously (  Sinha 
et al., 2004  ). 
  Subtraction hybridization screen 
  Subtraction hybridization screen was performed by using the PCR-
select cDNA subtraction kit (BD Biosciences) according to the manufac-
turer  ’  s instruction. 
  RT-PCR and luciferase assays 
  Total RNA prepared from cultured cells was used for semiquantitative or 
real-time RT-PCR analyses. Primer and probe sequences for   SM     -actin  , 
  SM22      ,   h1-calponin  ,   ACLP  ,   smoothelin-B  ,   myocardin  ,   MKL1  ,   MKL2  ,   Prx1  , 
  PECAM  ,   cardiac     -actin  ,   NeuroD  ,   GAPDH  , and   18S ribosomal RNA   were 
described previously (  Sinha et al., 2004, 2006  ;   Yoshida et al., 2004a  ,  b, 
2007  ). Primer and probe sequences for   Pitx2   were as follows: Pitx2 sense, 
5    -GCCAGCCTGAGACTGAAAGC-3    ; Pitx2 antisense, 5    -CTGCATACTG-
GCAAGCACTCA-3    ; and Pitx2 probe, 5    -GATTTCTTCGCGAGTGGAC-3    . 
Sequences for Pitx2 isoform-speciﬁ   c primers were described previously 
(  Ganga et al., 2003  ). Luciferase assays were performed as previously 
described (  Yoshida et al., 2003  ). 
  Western blotting and coimmunoprecipitation assays 
  Western blotting and coimmunoprecipitation assays were performed as 
previously described (  Yoshida et al., 2007  ). Antibodies used were as follows: 
SM     -actin (1A4; Sigma-Aldrich), SM22     (Abcam), GAPDH (Millipore), 
Flag (M2; Sigma-Aldrich), SRF (Santa Cruz Biotechnology, Inc.), and Pitx2 
(provided by T. Hjalt, Lund University, Lund, Sweden). 473 PITX2 INDUCES SMC DIFFERENTIATION   •   Shang et al.
   Lu ,   M.-F. ,   H.-T.    Cheng ,   M.J.    Kern ,   S.S.    Potter ,   B.    Tran ,   T.G.H.    Diekwisch ,  and 
 J.F.    Martin .   1999b .     prx-1   functions cooperatively with another   paired -
related homeobox gene,   prx-2  , to maintain cell fates within the craniofacial 
mesenchyme.     Development   .    126 : 495  –  504 .  
   Manabe ,   I. ,  and   G.K.    Owens .   2001 .   Recruitment  of  serum  response  factor  and 
hyperacetylation of histones at smooth muscle-specifi  c regulatory regions 
during differentiation of a novel P19-derived in vitro smooth muscle dif-
ferentiation system.       Circ. Res.     88 : 1127  –  1134 .    
   Mortensen ,   R.M. ,   D.A.    Conner ,   S.    Chao ,   A.A.T.    Geisterfer-Lowrance  , and   J.G.   
  Seidman  .   1992  .   Production of homozygous mutant ES cells with a single 
targeting construct.       Mol. Cell. Biol.     12 : 2391  –  2395 .  
   Oh ,   J. ,   J.A.    Richardson ,  and   E.N.    Olson .   2005 .   Requirement  of  myocardin-related 
transcription factor-B for remodeling of branchial arch arteries and smooth 
muscle  differentiation.     Proc. Natl. Acad. Sci. USA   .    102 : 15122  –  15127 .    
   Owens ,   G.K. ,   M.S.    Kumar ,  and   B.R.    Wamhoff .   2004 .   Molecular  regulation  of 
vascular smooth muscle cell differentiation in development and disease.   
  Physiol. Rev.     84 : 767  –  801 .    
   Pipes ,   G.C.T. ,   S.    Sinha ,   X.    Qi ,   C.-H.    Zhu ,   T.D.    Gallardo ,   J.    Shelton ,   E.E.  
 Creemers ,   L.    Sutherland ,   J.A.    Richardson ,   D.J.    Garry ,   et al  .   2005 .   Stem 
cells and their derivatives can bypass the requirement of myocardin for 
smooth muscle gene expression.       Dev. Biol.     288 : 502  –  513 .    
   Qiu ,   P. ,  and   L.    Li .   2002 .   Histone  acetylation  and  recruitment  of  serum  respon-
sive factor and CREB-binding protein onto SM22 promoter during SM22 
gene  expression.     Circ. Res.     90 : 858  –  865 .    
   Semina ,  E.V. ,  R.   Reiter ,  N.J.   Leysens ,  W.L.M.   Alward ,  K.W.   Small ,  N.A.   Datson , 
 J.    Siegel-Bartelt ,   D.    Bierke-Nelson ,   P.     Bitoun ,   B.U.    Zabel ,   et  al .   1996 . 
  Cloning and characterization of a novel   bicoid  -related homeobox tran-
scription factor gene,   RIEG  , involved in Rieger syndrome.       Nat. Genet.   
 14 : 392  –  399 .    
   Sinha ,   S. ,   M.H.    Hoofnagle ,   P.A.    Kingston ,   M.E.    McCanna ,  and   G.K.    Owens . 
 2004 .   Transforming  growth  factor-   1 signaling contributes to develop-
ment of smooth muscle cells from embryonic stem cells.       Am. J. Physiol. 
Cell Physiol.     287 : C1560  –  C1568 .    
   Sinha ,   S. ,   B.R.    Wamhoff ,   M.H.    Hoofnagle ,   J.    Thomas ,   R.L.    Neppl ,   T.    Deering , 
 B.P.    Helmke ,   D.K.    Bowles ,   A.V.    Somlyo ,  and   G.K.    Owens .   2006 . 
  Assessment of contractility of purifi  ed smooth muscle cells derived from 
embryonic stem cells.       Stem Cells   .    24 : 1678  –  1688 .    
   Topouzis ,   S. ,  and   M.W.    Majesky .   1996 .   Smooth  muscle  lineage  diversity  in  the 
chick embryo. Two types of aortic smooth muscle cell differ in growth 
and receptor-mediated transcriptional responses to transforming growth 
factor-   .     Dev. Biol.     178 : 430  –  445 .    
   Wang ,   D. ,   P.S.    Chang ,   Z.    Wang ,   L.    Sutherland ,   J.A.    Richardson ,   E.    Small ,   P.A.  
 Krieg ,  and   E.N.    Olson .   2001 .   Activation  of  cardiac  gene  expression  by 
myocardin, a transcriptional cofactor for serum response factor.       Cell   .  
 105 : 851  –  862 .    
   Yoshida ,   T.    2008 .   MCAT  elements  and  the  TEF-1  family  of  transcription  fac-
tors in muscle development and disease.       Arterioscler. Thromb. Vasc. Biol.   
 28 : 8  –  17 .    
   Yoshida ,   T. ,   S.    Sinha ,   F.    Dandr é  ,   B.R.    Wamhoff ,   M.H.    Hoofnagle ,   B.E.    Kremer , 
 D.-Z.    Wang ,   E.N.    Olson ,  and   G.K.    Owens .   2003 .   Myocardin  is  a  key 
regulator of CArG-dependent transcription of multiple smooth muscle 
marker genes.       Circ. Res.     92 : 856  –  864 .    
   Yoshida ,  T. ,   M.H.    Hoofnagle ,  and   G.K.    Owens .   2004a .   Myocardin  and  Prx1  con-
tribute to angiotensin II-induced expression of smooth muscle    -actin.  
  Circ. Res.     94 : 1075  –  1082 .    
   Yoshida ,   T. ,   K.    Kawai-Kowase ,  and   G.K.    Owens .   2004b .   Forced expression of 
myocardin is not suffi  cient for induction of smooth muscle differentia-
tion in multipotential embryonic cells.       Arterioscler. Thromb. Vasc. Biol.   
 24 : 1596  –  1601 .    
   Yoshida ,   T. ,   Q.    Gan ,   Y.    Shang ,  and   G.K.    Owens .   2007 .   Platelet-derived  growth 
factor-BB represses smooth muscle cell marker genes via changes in 
binding of MKL factors and histone deacetylases to their promoters.   
  Am. J. Physiol. Cell Physiol.     292 : C886  –  C895 .            
  References 
   Ai ,   D. ,   W.    Liu ,   L.    Ma ,   F.    Dong ,   M.-F.    Lu ,   D.    Wang ,   M.P.    Verzi ,   C.    Cai ,   P.J.  
 Gage ,   S.    Evans ,   et  al .   2006 .    Pitx2   regulates cardiac left-right asymme-
try by patterning second cardiac lineage-derived myocardium.       Dev. Biol.   
 296 : 437  –  449 .    
   Bergwerff ,   M. ,   A.C.    Gittenberger-de  Groot ,   L.J.    Wisse ,   M.C.    DeRuiter ,   A.  
 Wessels ,   J.F.    Martin ,   E.N.    Olson ,  and   M.J.    Kern .   2000 .   Loss  of  function 
of the   Prx1   and   Prx2   homeobox genes alters architecture of the great 
elastic arteries and ductus arteriosus.       Virchows Arch.     436 : 12  –  19 .    
   Carmeliet ,   P.    2000 .   Mechanisms  of  angiogenesis  and  arteriogenesis.      Nat. Med.   
 6 : 389  –  395 .    
   Chen ,   J. ,   C.M.    Kitchen ,   J.W.    Streb ,  and   J.M.    Miano .   2002 .   Myocardin:  a  com-
ponent of a molecular switch for smooth muscle differentiation.       J. Mol. 
Cell. Cardiol.     34 : 1345  –  1356 .    
   Drab ,   M. ,   H.    Haller ,   R.    Bychkov ,   B.    Erdmann ,   C.    Lindschau ,   H.    Haase ,   I.  
 Morano ,   F.C.    Luft ,  and   A.M.    Wobus .   1997 .   From  totipotent  embryonic 
stem cells to spontaneously contracting smooth muscle cells: a retinoic 
acid and db-cAMP in vitro differentiation model.       FASEB J.     11 : 905  –  915 .  
   Du ,   K.L. ,   H.S.    Ip ,   J.    Li ,   M.    Chen ,   F.    Dandre ,   W.    Yu ,   M.M.    Lu ,   G.K.    Owens , 
and   M.S.     Parmacek  .   2003  .   Myocardin is a critical serum response factor 
cofactor in the transcriptional program regulating smooth muscle cell dif-
ferentiation.     Mol. Cell. Biol.     23 : 2425  –  2437 .    
   Evans ,  A.L. ,  and   P.J.    Gage .   2005 .   Expression  of  the  homeobox  gene   Pitx2   in neu-
ral crest is required for optic stalk and ocular anterior segment develop-
ment.     Hum. Mol. Genet.     14 : 3347  –  3359 .    
   Gage ,   P.J. ,   H.    Suh ,  and   S.A.    Camper .   1999  .   Dosage requirement of Pitx2 for 
development of multiple organs.       Development   .    126 : 4643  –  4651 .  
   Gan ,   Q. ,   T.    Yoshida ,   J.    Li ,  and   G.K.    Owens .   2007 .   Smooth  muscle  cells  and 
myofi  broblasts use distinct transcriptional mechanisms for smooth muscle 
   -actin  expression.     Circ. Res.     101 : 883  –  892 .    
   Ganga ,   M. ,   H.M.    Espinoza ,   C.J.    Cox ,   L.    Morton ,   T.A.    Hjalt ,   Y.    Lee ,  and   B.A.  
 Amendt .   2003 .   PITX2  isoform-specifi  c regulation of atrial natriuretic 
factor expression: synergism and repression with Nkx2.5.       J. Biol. Chem.   
 278 : 22437  –  22445 .    
   Hautmann ,   M.B. ,   M.M.    Thompson ,   E.A.    Swartz ,   E.N.    Olson ,  and   G.K.    Owens . 
  1997  .   Angiotensin II-induced stimulation of smooth muscle    -actin 
expression by serum response factor and the homeodomain transcription 
factor MHox.       Circ. Res.     81 : 600  –  610 .  
   Hjalt ,  T.A. ,   E.V.    Semina ,   B.A.   Amendt ,  and   J.C.    Murray .   2000  .   The Pitx2 protein 
in mouse development.       Dev. Dyn.     218 : 195  –  200 .    
   Johansen ,   F.-E. ,  and   R.    Prywes .   1993 .   Identifi  cation of transcriptional activation 
and inhibitory domains in serum response factor (SRF) by using GAL4-
SRF constructs.       Mol. Cell. Biol.     13 : 4640  –  4647 .  
   Kioussi ,   C. ,   P.    Briata ,   S.H.    Baek ,   D.W.    Rose ,   N.S.    Hamblet ,   T.    Herman ,   K.A.  
 Ohgi ,   C.    Lin ,   A.    Gleiberman ,   J.    Wang ,   et  al .   2002 .   Identifi  cation of a 
Wnt/Dvl/   -Catenin   →   Pitx2 pathway mediating cell-type-specifi  c prolif-
eration during development.       Cell   .    111 : 673  –  685 .    
   Kitamura ,   K. ,   H.    Miura ,   S.    Miyagawa-Tomita ,   M.    Yanazawa ,   Y.    Katoh-Fukui , 
 R.    Suzuki ,   H.    Ohuchi ,   A.    Suehiro ,   Y.    Motegi ,   Y.    Nakahara ,   et  al .   1999 . 
  Mouse Pitx2 defi  ciency leads to anomalies of the ventral body wall, 
heart, extra- and periocular mesoderm and right pulmonary isomerism.   
  Development   .    126 : 5749  –  5758 .  
   Li ,   J. ,   X.    Zhu ,   M.    Chen ,   L.    Cheng ,   D.    Zhou ,   M.M.    Lu ,   K.    Du ,   J.A.    Epstein , 
and   M.S.    Parmacek .   2005 .   Myocardin-related  transcription  factor  B  is 
required in cardiac neural crest for smooth muscle differentiation and cardio-
vascular development.       Proc. Natl. Acad. Sci. USA   .    102 : 8916  –  8921 .    
   Li ,   L. ,   J.M.    Miano ,   B.    Mercer ,  and   E.N.    Olson .   1996 .   Expression  of  the   SM22      
promoter in transgenic mice provides evidence for distinct transcriptional 
regulatory programs in vascular and visceral smooth muscle cells.       J. Cell 
Biol.     132 : 849  –  859 .    
   Lin ,   C.R. ,   C.    Kioussi ,   S.    O ’ Connell ,   P.    Briata ,   D.    Szeto ,   F.    Liu ,   J.C.    Izpis ú a-
Belmonte ,  and   M.G.    Rosenfeld .   1999 .   Pitx2  regulates  lung  asymme-
try, cardiac positioning and pituitary and tooth morphogenesis.       Nature   .  
 401 : 279  –  282 .    
   Liu ,   C. ,   W.    Liu ,   M.-F.    Lu ,   N.A.    Brown ,  and   J.F.    Martin .   2001 .   Regulation  of 
left-right asymmetry by thresholds of Pitx2c activity.       Development   .  
 128 : 2039  –  2048 .  
   Liu ,  Y. ,   S.    Sinha ,   O.G.    McDonald ,  Y.    Shang ,   M.H.    Hoofnagle ,  and   G.K.    Owens . 
  2005  .   Kruppel-like factor 4 abrogates myocardin-induced activation of 
smooth muscle gene expression.       J. Biol. Chem.     280 : 9719  –  9727 .    
   Long ,   X. ,   E.E.    Creemers ,   D.-Z.    Wang ,   E.N.    Olson ,  and   J.M.    Miano .   2007 . 
  Myocardin is a bifunctional switch for smooth versus skeletal muscle dif-
ferentiation.     Proc. Natl. Acad. Sci. USA   .    104 : 16570  –  16575 .    
   Lu ,   M.-F. ,   C.    Pressman ,   R.    Dyer ,   R.L.    Johnson ,  and   J.F.    Martin .   1999a .   Function 
of Rieger syndrome gene in left-right asymmetry and craniofacial 
development.     Nature   .    401 : 276  –  278 .    